Logo UAB
2023/2024

Function of Biomolecules in Health and Illness

Code: 42888 ECTS Credits: 9
Degree Type Year Semester
4313772 Advanced Biotechnology OT 0 A
4313794 Biochemistry, Molecular Biology and Biomedicine OT 0 A

Contact

Name:
Susanna Navarro Cantero
Email:
susanna.navarro.cantero@uab.cat

Teaching groups languages

You can check it through this link. To consult the language you will need to enter the CODE of the subject. Please note that this information is provisional until 30 November 2023.

Teachers

Jaime Farrés Vicén
Xavier Pares Casasampera
Sandra Villegas Hernández
Ramon Barnadas Rodriguez
Maria Rosario Fernandez Gallegos
Mohammed Moussaoui Keribii
Maria Assumpcio Bosch Merino
Guillem Prats Ejarque
Julia Lorenzo Rivera
Irantzu Pallares Goitiz
Alicia Roque Cordova

Prerequisites

The requirements for the Master's degree. The classes will be mostly in Catalan, but they will also be taught in Spanish depending on the faculty. Classes could be conducted in English if requested by the students with sufficient advance notice, and if there is consensus within the student group and with the professor.


Objectives and Contextualisation

Upon completion of the module, the student will be able to:

  1. Plan experiments for the identification, expression, purification, and functional characterization of biomolecules.

  2. Analyze the structure and function of proteins using bioinformatics techniques.

  3. Relate structural and functional changes in biomolecules to pathologies.

  4. Select and apply methodologies for the design of enzyme inhibitors.

  5. Identify and characterize enzyme inhibitors as drugs.

  6. Utilize enzymatic technology for biomedical and biotechnological applications.

  7. Recognize biomolecules associated with human pathologies and use them as therapeutic targets.

  8. Associate specific diseases with the accumulation of misfolded proteins.

  9. Understand the molecular basis of diseases caused by dynamic mutations and epigenetic changes.

  10. Assess the functional role of membrane lipids and their involvement in specific pathologies.

  11. Familiarize themselves with the main techniques and facilities in a reference clinical biochemistry laboratory.

     

    Competencies

    Advanced Biotechnology

    Apply techniques for modifying living organisms or parts thereof to improve pharmaceutical and biotechnological processes and products, or to develop new products. (Specialization in Molecular and Therapeutic Biotechnology)

    Ability to synthesize, analyze alternatives, and engage in critical debate.

    Integrate the content of metabolic pathways in living organisms under normal, pathological, or exogenously modified conditions (Specialization in Molecular and Therapeutic Biotechnology).

    Apply acquired knowledge and problem-solving skills in new or unfamiliar environments within broader (or multidisciplinary) contexts related to their field of study.

    Effectively communicate their conclusions, as well as the knowledge and ultimate reasons underlying them, to specialized and non-specialized audiences in a clear and unambiguous manner.

    Possess learning skills that enable them to continue studying, largely through self-directed and autonomous work.

    Possess knowledge that provides the foundation or opportunity for originality in the development or application of ideas, often in a research context. Utilize and responsibly manage bibliographic information and computer resources related to biotechnology.

    Biochemistry, Molecular Biology, and Biomedicine

    Analyze research results to obtain new biotechnological or biomedical products and transfer them to society.

    Analyze and accurately interpret the molecular mechanisms operating in living organisms and identify their applications.

    Apply techniques for modifying living organisms or parts thereof to improve pharmaceutical and biotechnological processes and products, or to develop new products.

    Develop critical reasoning within the field of study and in relation to the scientific or business environment. Identify and utilize bioinformatic tools to solve problems related to biochemistry, molecular biology, and biomedicine.

    Integrate content in biochemistry, molecular biology, biotechnology, and biomedicine from a molecular perspective.

    Apply acquired knowledge and problem-solving skills in new or unfamiliar environments within broader (or multidisciplinary) contexts related to their field of study.

    Effectively communicate their conclusions, as well as the knowledge and ultimate reasons underlying them, to specialized and non-specialized audiences in a clear and unambiguous manner.

    Possess learning skills that enable them to continue studying, largely through self-directed and autonomous work.

    Possess knowledge that provides the foundation or opportunity for originality in the development or application of ideas, often in a research context.

    Utilize and manage bibliographic information and computer resources related to biochemistry, molecular biology, or biomedicine. Utilize scientific terminology to argue research results and effectively communicate them orally and in writing.


Competences

    Advanced Biotechnology
  • Apply techniques for modifying living beings or parts of these in order to improve pharmaceutical and biotechnological processes and products or develop new products. (Specialisation in molecular and therapeutic biotechnology)
  • Communicate and justify conclusions clearly and unambiguously to both specialist and non-specialist audiences.
  • Continue the learning process, to a large extent autonomously.
  • Integrate the contents of the metabolic paths of living beings in normal conditions, pathological conditions, or conditions that are modified exogenously (specialisation in molecular and therapeutic biotechnology)
  • Solve problems in new or little-known situations within broader (or multidisciplinary) contexts related to the field of study.
  • Synthesise, weigh up alternatives and engage in critical discussion.
  • Use acquired knowledge as a basis for originality in the application of ideas, often in a research context.
  • Use and manage bibliography and IT resources related to biotechnology responsibly.
    Biochemistry, Molecular Biology and Biomedicine
  • Analyse and correctly interpret the molecular mechanisms operating in living beings and identify their applications.
  • Analyse research results to obtain new biotechnological or biomedical products to be transferred to society.
  • Apply techniques for modifying living beings or parts of these in order to improve pharmaceutical and biotechnological processes and products or develop new products.
  • Communicate and justify conclusions clearly and unambiguously to both specialist and non-specialist audiences.
  • Continue the learning process, to a large extent autonomously.
  • Develop critical reasoning within the subject area and in relation to the scientific or business context.
  • Identify and use bioinformatic tools to solve problems in biochemistry, molecular biology and biomedicine.
  • Integrate contents in biochemistry, molecular biology, biotechnology and biomedicine from a molecular perspective.
  • Solve problems in new or little-known situations within broader (or multidisciplinary) contexts related to the field of study.
  • Use acquired knowledge as a basis for originality in the application of ideas, often in a research context.
  • Use and manage bibliography and IT resources related to biochemistry, molecular biology or biomedicine.
  • Use scientific terminology to account for research results and present these orally and in writing.

Learning Outcomes

  1. Analyse research results to obtain new biotechnological or biomedical products to be transferred to society.
  2. Communicate and justify conclusions clearly and unambiguously to both specialist and non-specialist audiences.
  3. Continue the learning process, to a large extent autonomously.
  4. Describe processes and methodologies for designing or transforming biomolecules for application in therapy.
  5. Descriure els processos i les metodologies per al disseny o transformació de biomolècules per a la seva aplicació terapèutica.
  6. Develop critical reasoning within the subject area and in relation to the scientific or business context.
  7. Identificar mecanismes moleculars responsables de malalties.
  8. Identificar molècules que intervenen en funcions biològiques importants i la seva variació en situacions de malaltia.
  9. Identify molecular mechanisms responsible for diseases.
  10. Recognise the molecular mechanisms of important functions in biomedicine.
  11. Reconèixer els mecanismes moleculars de funcions rellevants en biomedicina.
  12. Solve problems in new or little-known situations within broader (or multidisciplinary) contexts related to the field of study.
  13. Synthesise, weigh up alternatives and engage in critical discussion.
  14. Use acquired knowledge as a basis for originality in the application of ideas, often in a research context.
  15. Use and manage bibliography and IT resources related to biochemistry, molecular biology or biomedicine.
  16. Use and manage bibliography and IT resources related to biotechnology responsibly.
  17. Use bioinformatic procedures to analyse the active centre of enzymes and design drugs.
  18. Use scientific terminology to account for research results and present these orally and in writing.
  19. Utilitzar procediments bioinformàtics per a l'anàlisi del centre actiu dels enzims i el disseny de fàrmacs.

Content

Block 1: Identification, Obtaining, and Purification of Biomolecules. Functional Characterization.

Practical concepts for protein purification. Methods for identifying potential substrates or inhibitors and detecting enzymatic activity. Practical considerations for enzymatic assays. Applied aspects of enzymatic kinetics. Identification of functional regions of enzymes using bioinformatic tools. Practical session in the computer laboratory. Structural and functional analysis of enzyme inhibitors acting as drugs. Practical session in the computer laboratory.

Drug repurposing: Identification and development of new uses for existing drugs. Drug repurposing: Identification and development of new uses for existing drugs.

 

Block 2: Enzymes Associated with Human Pathologies. Diagnostic and Therapeutic Applications.

Role of oxidoreductases in alcohol and aldehyde metabolism.

Relationship with alcoholism. Enzymes involved in retinoid metabolism. Associated pathologies. Enzymes modifying chromatin and their role in human pathologies. Enzyme replacement therapy. Enzyme activators. Pharmacological chaperones or pharmacoperones. Therapeutic applications. Enzymes and nanomedicine. Encapsulation of enzymes. Controlled drug release. Role of infectious proteins in degenerative diseases. Strategies for treating lysosomal diseases: Enzyme, cellular, and gene therapy. Proteases and protease inhibitors. Biomedical and high-affinity binding kinetic applications. Yeast as a model organism. Three applications in biomolecule characterization: protein-lipid interactions, protein-protein interactions, and genetic interactions.

 

Block 3: Conformational Diseases.

Proteostasis and conformational diseases. Therapies under development forconformational diseases: Introduction to conformational diseases. Light chain amyloidosis. Alzheimer's disease.

 

Block 4: Membrane Lipids in Biomedicine.

Role of lipids in various functions and dysfunctions of biomembranes: dynamics of lipid microdomains (lipid rafts, etc.); endocytosis and exocytosis; oxidative stress; apoptosis. Study techniques.

 

Block 5: Visits to the Clinical Biochemistry Laboratory, Parc Taulí Clinic Hospital.

Visit the automated rapid response laboratory (CORE lab). Analysis of retinoids by HPLC. Immunoenzymatic techniques in clinical biochemistry.

 

Block 6: In silico strategies for pharmacological identification.

 Identification of pharmacophores against a specific protein involved in antibiotic resistance.

 In silico screening using molecular docking.

 Molecular dynamics and affinity energy calculations.


Methodology

The module consists of theoretical classes, computer lab practical classes, a visit to a reference Clinical Biochemistry laboratory, and a seminar presentation by the student. The organization and teaching methodology for these educational activities are described below.

Theory classes:

The content of the theory program will be primarily delivered by professors in the form of lectures with audiovisual support. The presentations used by the professor in class will be made available beforehand on the Virtual Campus of the subject. It is recommended that students have access to this material as a support for their classes. It is advised that students regularly consult the recommended books listed in the Bibliography section of this teaching guide to consolidate and clarify, if necessary, the content explained in class. It is also advisable for students to use the links provided in the presentations of different topics, which contain videos and animations related to the processes explained in class.

Computer lab practical classes:

Students will be directly called to the classroom for the development of the session. The work will be individual, and it will be important for the student to have prior knowledge of the software to be used.

Visit to a reference Clinical Biochemistry laboratory:

The session will take place at the Clinical Analysis Laboratory of the Parc Taulí Hospital in Sabadell, where the student will receive explanations about the functioning of all the facilities and the methodologies used by healthcare professionals. After the visit, a multiple-choice knowledge test will be conducted.

Seminar presentation:

Each student will be required to give a seminar presentation.

The student will prepare a seminar on a topic agreed upon with a tutor professor and will present it publicly in class using audiovisual means.

Preparation tutorials for the seminar:

There will be a group tutorial session led by the module coordinator to distribute the seminar topics and propose the general organization of the material to be presented. Students may also have individual tutorials with professors directly involved in the chosen topic to guide them in the preparation of the material.

Note: 15 minutes of a class, within the schedule established by the institution/program, will be reserved for students to complete evaluation surveys of the faculty's performance and evaluation of the subject/module.

Annotation: Within the schedule set by the centre or degree programme, 15 minutes of one class will be reserved for students to evaluate their lecturers and their courses or modules through questionnaires.


Activities

Title Hours ECTS Learning Outcomes
Type: Directed      
Oral presentation 5 0.2 1, 5, 6, 7, 8, 11, 18
Practical activities in the computer classroom 8 0.32 8, 11, 10, 19
Theory classes 44 1.76 5, 7, 8, 11, 19
Visit to clinical laboratories 4 0.16 6, 9, 12
Type: Supervised      
Preparation and presentation of an individual work 20 0.8 13, 5, 4, 7, 9, 8, 12, 2, 3, 11, 10, 15, 17, 18
Type: Autonomous      
Independent work of the student 81 3.24 1, 13, 6, 12, 3, 14, 16, 18

Assessment

  • Attendance and active participation in class:

In addition to attendance, the degree of participation, discussion, and resolution of questions posed by the professor in different areas of the subject will be evaluated. An assessment of this activity will be submitted by the professor to the module coordinator after each class. This evaluation will account for 10% of the final grade.

  • Preparation and oral presentation of a seminar

Public presentation of a seminar in class, followed by discussion. This component will account for 20% of the final grade for students who have presented it.

  • Written exams:

The submission of papers or written exams requested by the professors for each part of the subject will be evaluated. This component will account for 40% of the final grade.

Additionally, the overall utilization of seminar sessions will be assessed through written questions. This component will account for 10% of the final grade.

  • Classroom practicals

Reports or assignments from classroom practicals 20%

To participate in the recovery process, students must have been previously evaluated in a set of activities whose weight is equivalent to at least two-thirds of the total grade for the subject or module. Therefore, students will receive a "Not Evaluable" grade when the weight of the assessment activities performed is less than 67% of the final grade.

Attendance at practical sessions (or fieldwork) is mandatory. Students will receive a "Not Evaluable" grade if their absences exceed 20% of the scheduled sessions.

  • Important: If plagiarism is detected in any of the submitted works, it may result in the student failing the entire module.

This subject/module does not provide for a single assessment.


Assessment Activities

Title Weighting Hours ECTS Learning Outcomes
Attendance and active class participation 10% 38 1.52 4, 7, 9, 8, 11, 10, 14, 19, 17
Classroom practical work 20% 5 0.2 1, 5, 4, 6, 7, 9, 8, 11, 10, 14, 16, 15, 19, 17, 18
Preparation and oral presentation of a seminar 20% 5 0.2 1, 13, 6, 12, 2, 3, 14, 16, 18
Seminar examination 10% 5 0.2 12, 2, 3, 14, 18
Theory exams 40% 10 0.4 13, 5, 4, 7, 9, 8, 11, 10, 14, 17, 18

Bibliography

- Abbenante, G., Fairlie, D.P. "Protease Inhibitors in the Clinic". Medicinal Chemistry, 2005, 1, 71-104

 

- LA Bagatolli, JH Ipsen, AC Simonsen, OG Mouritsen An outlook on organization of lipids in membranes: Searching for a realistic connection with the organization of biological membranes Progress in Lipid Research

49 (2010) 378-389

 

- Bommarius, A.S., Riebel, B.R. "Biocatalysis - Fundamentals and Applications". 2004. Wiley-VCH. Weinheim.

 

- Bieth, J.G. "Theoretical and Practical Aspects of Proteinase Inhibition Kinetics". Methods in Enzymology.

1995, Vol 248, pp. 59-84. Academic Press. NY.

 

- Carey, P.R. (ed.) "Protein engineering and design". 1996. Academic Press. New York.

 

- O Ces & X Mulet Physical coupling between lipids and proteins: a paradigm for cellular control Signal

Transduction 6 (2006) 112 - 132

 

- Chaplin, M.F., Bucke, C. "Enzyme Technology". 1990. Cambridge University Press.

 

- Copeland, R.A. "Enzymes. A practical introduction to structure, mechanism and data analysis". 2000. Wiley-VCH. New York.

 

- Copeland, R.A. "Evaluation of enzyme inhibitors in drug discovery" 2005. Wiley. Hoboken. New Jersey

 

- Cornish-Bowden, A. "Fundamentals of enzyme kinetics". 3rd ed. 2004. Portland Press. London.

 

- Chávez, M. et al: Selección de temas: Purificación de Enzimas. Inmovilización de Enzimas. Fundamentos de

Cinética de Reacciones Enzimáticas. Cinética de Inhibición de Unión fuerte. En Enzimología Biotecnológica.

2007. Editora ELFOS. La Habana.

 

- De Leenheer, A.P., Lambert, W.E., Nelis, H.J. (Editors) "Modern chromatographic analysis of vitamins" 2nd edition. 1992. Chromatographic Science Series vol 60. Marcel Dekker Inc, New York.

 

- Deulofeu, R., Olmedilla, B. (Editors) "Vitaminas, Vol 2, Liposolubles" 2006. Sociedad Española de Química

Clínica.

 

- Engel, P.C. (ed.) "Enzymology Labfax". 1996. Academic Press, San Diego, CA.

 

- Eisental, R., Danson, M.J. "Enzyme Assays". 2002. 2ª ed. Oxford Univ. Press. Oxford

 

- H. Feldmann, editor "Yeast: Molecular and Cell Biology", (2012) Wiley-Blackwell

 

- Fersht, A., "Structure and Mechanism in Protein Science". 1999. W.H. Freeman. New York.

 

- KS. George & S Wu Lipid raft: A floating island of death or survival. Toxicology and Applied Pharmacology

259 (2012) 311-319

 

- Glusker, J.P., Lewis, M., Rossi, M. "Crystal Structure Analysis for Chemists and Biologists". 1994. VCH Publishers

 

- Janson, J-C., Ryden L. "Protein Purification, Principles, High Resolution Methods and Applications". 1998. R.K. Wiley & Sons , Inc, NY

 

- Grunwald, P. "Biocatalysis. Biochemical Fundamentals and Applications". 2009. Imperial college Press, London.

 

- Knight C.G. "Active Site Titration of Peptidases". Methods in Enzymology. 1995. Vol 248, pp. 85-100. Academic Press. NY.

 

- McGrath, B.M., Walsh, G. (Editors) "Directory of Therapeutic Enzymes". 2005. CRC, Taylor & Francis.

 

- McPherson, A. (2003) "Introduction to macromolecular crystallography" John Wiley & Sons, Inc., New Jersey

 

- Núñez de Castro, I. "Enzimología". 2001, Pirámide, Madrid.

 

- Pandey, A., Webb, C., Soccol, C.R., Larroche, C. "Enzyme Technology". 2006. Springer-Verlag

 

- Price, N.C., Stevens, L. "Fundamentals of Enzymology". 1999. 3ª edició. Oxford University Press. Oxford.

 

- M. Ramírez-Alvarado, J.W. Kelly, C. M. Dobson (2010) Protein Misfolding diseases: current and emerging principles and therapies. Ed. Wiley

 

- Reymond, J.-L. "Enzyme assays: High-throughput screening, genetic selection and fingerprinting". 2006, Wiley-VCH.

 

- Rhodes G. "Crystallography made crystal clear" 2006. 3rd ed. Elsevier Academic Press.

 

- Tietz, N. W. "Textbook of Clinical Chemistry". 1999. 3rd ed. WB Saunders.

 

- G. van Meer, DR Voelker & GW Feigenson Membrane lipids: where they are and how they behave Nature

Reviews (Molecular Cell Biology) 9 (2008) 112-124


Software

Pymol vs 2.5

Autodock Vina

Gromacs

VMD (Visual Molecular Dynamics)